JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 24 No. 9 812-815
© 1983 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedland, R. P.
Right arrow Articles by Rosen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedland, R. P.
Right arrow Articles by Rosen, M.

Labeled Choline and Phosphorylcholine: Body Distribution and Brain Autoradiography: Concise Communication

Robert P. Friedland, Chester A. Mathis, Thomas F. Budinger, Brian R. Moyer and Mark Rosen

Donner Laboratory, Lawrence Berkeley Laboratory, University of California, Berkeley
Veterans Administration Medical Center, Martinez, California
Department of Neurology, University of California, Davis

Correspondence: For reprints contact: Robert P. Friedland, University of California, Veterans Administration Medical Center (127), 150 Muir Rd., Martinez, CA 94553.

ABSTRACT

Following intravenous injection of labeled choline or phosphorylcholine in rats and mice, the brain uptake as percent injected dose was less than 0.2% with 6–12% going to kidney and 3–6% to liver. A study of [14C]choline autoradiography in a stump-tailed macaque demonstrated a five- to sixfold greater uptake in gray matter than in white matter. Dynamic positron imaging of [11C]choline in a rhesus monkey demonstrated rapid brain uptake followed by rapid washout, with heavy late uptake in muscle. The use of labeled choline and choline analogs as imaging agents in human studies is constrained by the low brain uptake relative to extracerebral tissues.




This article has been cited by other articles:


Home page
JNMHome page
R. M. Pieterman, T. H. Que, P. H. Elsinga, J. Pruim, J. W.G. van Putten, A. T.M. Willemsen, W. Vaalburg, and H. J.M. Groen
Comparison of 11C-Choline and 18F-FDG PET in Primary Diagnosis and Staging of Patients with Thoracic Cancer
J. Nucl. Med., February 1, 2002; 43(2): 167 - 172.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. R. DeGrado, R. E. Coleman, S. Wang, S. W. Baldwin, M. D. Orr, C. N. Robertson, T. J. Polascik, and D. T. Price
Synthesis and Evaluation of 18F-labeled Choline as an Oncologic Tracer for Positron Emission Tomography: Initial Findings in Prostate Cancer
Cancer Res., January 1, 2000; 61(1): 110 - 117.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1983 by the Society of Nuclear Medicine.